Thorsten Roman Mempel
- Massachusetts General Hospital · Microbiology & Immunology (topic-inferred)
- Massachusetts General Hospital (no department on record)
From the FY2024 NIH awards this investigator leads as contact PI. The department is the award's.
FY2024 NIH rank #6,216
- R01 Holder
- Early Career
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID 8662677Search this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2024 through FY2026Career claims are limited to the years shown.
NIH Funding · FY2024
Linked Award Amount
$1.8M
Full award amounts, FY2024
Award Records
3
Records listing this PI
Award-Linked Rank
#6,216
By linked amount among FY2024 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2024 award records by amount
NIH award records listing Thorsten Roman Mempel as a PI. Multi-PI records show the full award amount for context.
- 1S10OD036287-01S10Contact PILeica Stellaris 8 Falcon confocal microscope$872.7Kaward amount
- 5R01AI123349-08R01Contact PICellular mechanisms by which exhausted T cell responses are restoredMassachusetts General Hospital · Microbiology & Immunology (topic-inferred)$490.6Kaward amount
- 5R01AI163223-04R01Contact PIA mechanism to minimize auto-reactivity in the tissue-resident memory T cell poolMassachusetts General Hospital · Microbiology & Immunology (topic-inferred)$478.1Kaward amount
Award organization
Organizations that administered FY2024 awards listing Thorsten Roman Mempel as a PI.
FY2024 award administered by Massachusetts General Hospital (MA).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2024First NIH AwardMassachusetts General Hospital
- 2024$500K Cumulative Funding
- 2024$1M Cumulative Funding
- 2024Entered Top 50% NationallyRanked #6216
- 2025$2M Cumulative Funding
- 2025R01 Grant Holder